Tag:

social media

Latest Headlines

Latest Headlines

Top 10 pharma companies in social media

Social media success in consumer marketing has advanced beyond counting fans and followers. Today it's all about shares, retweets and links that indicate real consumer engagement with brands....

Congressman pushes to unshackle pharma on social media

A congressman is taking aim at perceived flaws in FDA's long-awaited, much-discussed guidance on the use of Twitter.

House bill would force FDA to ease up on social media

A Missouri congressman wants to know why the pharma industry is sitting on the sidelines of social media. Actually, Rep. Billy Long (R-MO) has an idea why--and he's proposing legislation to change it. He recently introduced H.R. 2479, which would force the FDA to let pharma share more info about its products online.

Social listening should be a no-brainer for pharma, study finds

In a recent study divining social insights for pharma, several companies noted they had never thought of using social media that way. The other significant feedback centered on regulations, particularly adverse events and the question of whether findings via social listening would have to be reported.

High-profile Huntington's disease film scores on social media, but where was pharma?

HBO premiered an award-winning short documentary about Huntington's disease, a rare, hereditary neurological malady, on Monday night. The film follows actress and filmmaker Marianne Palka as she finds out the results of her genetic test. If someone has a parent with the disease as she did, they have a 50/50 chance of getting the disease. The missing voice? Pharma.

Bayer, Boehringer lead rapid rise in pharma's social media output

Large pharma companies are posting 530% more tweets a week than in 2013, a study by Ogilvy Healthworld found. The healthcare communications group tracked the social media activity of 14 large pharma companies for one week per month over three months.

Pharma's getting savvier about social, with Boehringer, Bayer leading the pack

Bigger isn't necessarily better when it comes to social media. But bigger is certainly better than drugmakers were doing a couple of years ago. Some companies are actually getting it right now, Ogilvy Healthworld says.

Fed-up MD Anderson oncologist jumps on social media to fight drug prices

Flush with success in negotiating discounts for hepatitis C drugs, payers are promising to strong-arm drugmakers in other treatment classes, too--cholesterol and cancer, for instance. They'll have more than one oncologist on their sides: A top doctor at the MD Anderson Cancer Center, fed up with cancer drug prices, plans a social media protest.

BIO is preparing small biotechs for life in the social media maelstrom

Last year the campaign for Chimerix to give an experimental cancer drug to a 7-year-old gave biopharma firms another reason to be wary of the power of social media. Having seen Chimerix be engulfed by the social media maelstrom, BIO is working to equip small biotechs with the skills they will need if they find themselves in a similar situation.

FDA to publish guidance on social media and clinical trial e-consent in 2015

The FDA has released a list of almost 100 draft drug guidance documents it plans to introduce or update in 2015. The documents cover a range of biotech IT-related topics, including electronic informed consent in clinical trials, links to third-party sites in social media adverts and statistical approaches to showing biosimilarity.